Pregled bibliografske jedinice broj: 460941
Association study of MDR1 and 5-HT2C genetic polymorphisms and antipsychotic-induced metabolic disturbances in female patients with schizophrenia
Association study of MDR1 and 5-HT2C genetic polymorphisms and antipsychotic-induced metabolic disturbances in female patients with schizophrenia // Pharmacogenomics journal, 11 (2011), 1; 35-44 doi:10.1038/tpj.2010.7 (međunarodna recenzija, članak, znanstveni)
CROSBI ID: 460941 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Association study of MDR1 and 5-HT2C genetic polymorphisms and antipsychotic-induced metabolic disturbances in female patients with schizophrenia
Autori
Rojnić Kuzman, Martina ; Medved, Vesna ; Božina, Nada ; Grubišin, Jasmina ; Jovanović, Nikolina ; Sertić, Jadranka
Izvornik
Pharmacogenomics journal (1470-269X) 11
(2011), 1;
35-44
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni
Ključne riječi
5-HT2C; MDR1; genetic polymorphism; metabolic abnormalities;
(5-HT2C; MDR1; genetic polymorphism; metabolic abnormalities)
Sažetak
The objective of this study was to determine the association of 5-HT2C (serotonin 2C receptor) and MDR1 (multidrug resistant protein) genetic polymorphisms and antipsychotic-induced metabolic abnormalities among female patients with DSM IV schizophrenia spectrum disorders. We have previously reported the associations of -759CT 5- HT2C and G2677T and C3435T MDR1 genetic polymorphisms and olanzapine/risperidone-induced weight gain in a similar sample of patients. Here, we included a total of 101 previously non- medicated female patients treated with olanzapine/risperidone over a 3-month period. The variables analyzed included fasting glucose, total cholesterol, low-density lipoprotein, high-density lipoprotein and triglyceride levels in blood, blood pressure and waist circumferences. We observed significant association of -759T 5-HT2C genetic variant and greater increase in waist circumference (P=0.03), fasting glucose level (P=0.046) and triglyceride level (P=0.045) in blood after a 3-month period. The 2677T and 3435T MDR1 genetic variants were significantly associated with the greater increase in fasting glucose level in blood when patients were using olanzapine (P<0.001 and P=0.028, respectively). Our data indicate a possible influence of -759CT 5-HT2C and MDR1 G2677T and C3435T MDR1 genetic polymorphisms on the development of metabolic abnormalities among female patients treated with olanzapine/risperidone.The Pharmacogenomics Journal advance online publication, 2 March 2010 ; doi:10.1038/tpj.2010.7.
Izvorni jezik
Engleski
Znanstvena područja
Kliničke medicinske znanosti
POVEZANOST RADA
Projekti:
108-1080134-0136 - Funkcijska genomika i proteomika rizičnih čimbenika ateroskleroze (Sertić, Jadranka, MZOS ) ( CroRIS)
108-1083509-3513 - Farmakogenetska varijabilnost u psihijatrijskih bolesnika (Mihaljević-Peleš, Alma, MZOS ) ( CroRIS)
Ustanove:
Medicinski fakultet, Zagreb,
Klinički bolnički centar Zagreb
Profili:
Martina Rojnić Kuzman
(autor)
Vesna Medved
(autor)
Jasmina Grubišin
(autor)
Nada Božina
(autor)
Jadranka Sertić
(autor)
Nikolina Jovanović
(autor)
Citiraj ovu publikaciju:
Časopis indeksira:
- Current Contents Connect (CCC)
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus
- MEDLINE